Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Related Posts
Adapting to a Changing Research Funding Landscape
In a recent video interview with Applied Clinical Trials, Michael Miller, chief operating officer, Quanterix, discussed how the clinical research…
DIA’s Impact on the Clinical Research Industry
ACT: What kind of impact do you hope DIA and its conferences have within the clinical trials industry? Pierce: DIA…
Results From Phase III SPACE Trial of AJOVY Show Promise in Episodic Migraine Prevention
Image Credit: © yodiyim – stock.adobe.com Teva Pharmaceuticals has shared new results from the Phase III SPACE clinical trial (NCT03539393)…
